Methods for treating nasal polyposis by administering an IL-4R antagonist
US10059771B2 · kind B2 · utility
18Cited by
26References
57Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 20, 2014 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Jun 20, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating nasal polyposis. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.